4//SEC Filing
Long Alison S 4
Accession 0001209191-23-054339
CIK 0001806310other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:41 PM ET
Size
5.5 KB
Accession
0001209191-23-054339
Insider Transaction Report
Form 4
Long Alison S
Director
Transactions
- Award
Stock Option (right to buy)
2023-11-01+43,800→ 43,800 totalExercise: $2.38Exp: 2033-11-01→ Common Stock (43,800 underlying)
Footnotes (1)
- [F1]The shares vest in 36 equal monthly installments commencing on December 1, 2023 such that the shares will be fully vested on November 1, 2026, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001891712
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:41 PM ET
- Size
- 5.5 KB